Portfolio Holdings Detail for ISIN IE00BGPP8L80
Stock Name / Fund iShares Edge MSCI World Minimum Volatility UCITS ETF GBP Hedged (Acc)
Issuer Blackrock
Entity holding fund iShares VI Public Limited Company
Entity Type
Entity LEI 549300VML6THE3JJOS76
ETF Ticker WMVG(GBP) LSE
ETF Ticker WMVG.L(GBP) LSE

Holdings detail for REGN

Stock Name	Regeneron Pharmaceuticals Inc
Ticker	REGN(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US75886F1075
LEI	549300RCBFWIRX3HYQ56

Show aggregate REGN holdings

News associated with REGN

Regeneron And Sanofi : CHMP Recommends EU Approval Of Dupixent For Chronic Spontaneous Urticaria: (RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) and Sanofi announced that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has adopted a positive opinion recommending the approval of Dupixent (dupilumab) in the European Union for treating c - 2025-09-22 02:12:20
Peek Under The Hood: JEPQ Has 10% Upside: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-08 08:26:56
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Consensus Rating of “Moderate Buy” by Brokerages: Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the twenty-six analysts that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, six have issued a hold rating, sixteen have assigned a buy rating and three […] - 2025-08-26 02:16:48
LABU, INCY, UTHR, REGN: ETF Outflow Alert: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Regeneron Pharmaceuticals (NASDAQ:REGN) versus Cadrenal Therapeutics (NASDAQ:CVKD) Head-To-Head Analysis: Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) and Cadrenal Therapeutics (NASDAQ:CVKD – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability and earnings. Volatility and Risk Regeneron Pharmaceuticals has a beta […] - 2025-08-20 02:22:48
Truist Financial Cuts Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $812.00: Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target reduced by Truist Financial from $940.00 to $812.00 in a research note published on Monday,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. REGN has been the topic of several other reports. The Goldman Sachs Group dropped their price target on […] - 2025-08-14 03:00:52
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Position Raised by Blair William & Co. IL: Blair William & Co. IL lifted its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.2% in the 1st quarter, Holdings Channel reports. The fund owned 1,282 shares of the biopharmaceutical company’s stock after buying an additional 27 shares during the period. Blair William & Co. IL’s holdings in Regeneron Pharmaceuticals were worth […] - 2025-08-11 06:26:50
Harbour Investments Inc. Sells 32 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Harbour Investments Inc. reduced its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 7.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 403 shares of the biopharmaceutical company’s stock after selling 32 shares during the quarter. Harbour Investments Inc.’s holdings in […] - 2025-08-07 09:40:47
We Did The Math SPYX Can Go To $58: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-07 08:58:54
409 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Purchased by Arkadios Wealth Advisors: Arkadios Wealth Advisors purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 409 shares of the biopharmaceutical company’s stock, valued at approximately $259,000. Several other institutional investors and hedge funds also […] - 2025-08-07 05:38:53
Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price Expected to Rise, BMO Capital Markets Analyst Says: Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its price target upped by stock analysts at BMO Capital Markets from $600.00 to $640.00 in a research report issued on Monday,Benzinga reports. The firm currently has an “outperform” rating on the biopharmaceutical company’s stock. BMO Capital Markets’ price target indicates a potential upside of 12.30% from […] - 2025-08-06 03:12:48
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives $828.86 Consensus Target Price from Brokerages: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has been given a consensus rating of “Moderate Buy” by the twenty-four ratings firms that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation, fifteen have assigned a buy recommendation and two […] - 2025-08-04 02:59:01
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 19:31:54
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:40:40
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:35:36
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:02:25
Nasdaq 100 Movers: MRVL, REGN: In early trading on Friday, shares of Regeneron Pharmaceuticals, topped the list of the day's best performing components of the Nasdaq 100 index, trading up 3.6%. Year to date, Regeneron Pharmaceuticals, has lost about 20.7% of its value. And the worst performing Nasdaq 100 co - 2025-08-01 11:30:09
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Choreo LLC: Choreo LLC boosted its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,746 shares of the biopharmaceutical company’s stock after acquiring an additional 32 shares during the period. Choreo LLC’s holdings in Regeneron Pharmaceuticals […] - 2025-07-24 07:22:56
Crestwood Advisors Group LLC Grows Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Crestwood Advisors Group LLC increased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 467 shares of the biopharmaceutical company’s stock after purchasing an additional 25 shares during the quarter. Crestwood Advisors Group […] - 2025-07-24 05:47:12
Kestra Private Wealth Services LLC Has $1.31 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Kestra Private Wealth Services LLC grew its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.9% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,058 shares of the biopharmaceutical company’s stock after buying an additional 132 shares during the quarter. […] - 2025-07-23 07:50:58
Larson Financial Group LLC Has $34,000 Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Larson Financial Group LLC lessened its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 34.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 53 shares of the biopharmaceutical company’s stock after selling 28 shares during the quarter. Larson […] - 2025-07-23 06:30:53
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Alps Advisors Inc.: Alps Advisors Inc. raised its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 71.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 530 shares of the biopharmaceutical company’s stock after purchasing an additional 220 shares during the quarter. Alps Advisors Inc.’s […] - 2025-07-17 05:50:54
Stratos Wealth Partners LTD. Sells 115 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Stratos Wealth Partners LTD. trimmed its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 18.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 506 shares of the biopharmaceutical company’s stock after selling 115 shares during the period. Stratos Wealth Partners […] - 2025-07-16 04:58:54
Allworth Financial LP Reduces Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Allworth Financial LP trimmed its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 14.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 821 shares of the biopharmaceutical company’s stock after selling 137 shares during the period. Allworth Financial […] - 2025-07-15 08:20:00
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $584.00: Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target increased by UBS Group from $560.00 to $584.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. Several other research analysts also recently commented on REGN. BMO Capital Markets reduced their price objective on Regeneron […] - 2025-07-14 03:30:48
Brown Advisory Inc. Reduces Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Brown Advisory Inc. lowered its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,269 shares of the biopharmaceutical company’s stock after selling 247 shares during the quarter. Brown Advisory Inc.’s […] - 2025-07-13 05:54:54
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Holdings Cut by D.A. Davidson & CO.: D.A. Davidson & CO. reduced its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.8% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 732 shares of the biopharmaceutical company’s stock after selling 21 shares during the quarter. D.A. […] - 2025-07-11 05:32:52
Brokerages Set Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) PT at $813.57: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has received an average recommendation of “Moderate Buy” from the twenty-five ratings firms that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, six have issued a hold rating, fifteen have assigned a buy rating and three have issued […] - 2025-07-10 03:07:00
DAVENPORT & Co LLC Makes New Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): DAVENPORT & Co LLC purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 427 shares of the biopharmaceutical company’s stock, valued at approximately $271,000. A number of other institutional […] - 2025-07-09 05:11:22
Bessemer Group Inc. Sells 3,860 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Bessemer Group Inc. decreased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 76.0% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,218 shares of the biopharmaceutical company’s stock after selling 3,860 shares during the period. Bessemer Group […] - 2025-07-01 05:46:52

iShares Edge MSCI World Minimum Volatility UCITS ETF GBP Hedged (Acc) REGN holdings

Date	Number of REGN Shares Held	Base Market Value of REGN Shares	Local Market Value of REGN Shares	Change in REGN Shares Held	Change in REGN Base Value	Current Price per REGN Share Held	Previous Price per REGN Share Held
2025-11-12 (Wednesday)	11,809	USD 8,050,431	USD 8,050,431
2025-11-11 (Tuesday)	11,809	USD 7,965,761	USD 7,965,761	0	USD 233,936	USD 674.55	USD 654.74
2025-11-10 (Monday)	11,809	USD 7,731,825	USD 7,731,825	0	USD -32,947	USD 654.74	USD 657.53
2025-11-07 (Friday)	11,809	USD 7,764,772	USD 7,764,772	0	USD 125,884	USD 657.53	USD 646.87
2025-11-06 (Thursday)	11,809	USD 7,638,888	USD 7,638,888	0	USD 31,648	USD 646.87	USD 644.19
2025-11-05 (Wednesday)	11,809	USD 7,607,240	USD 7,607,240	0	USD 191,188	USD 644.19	USD 628
2025-11-04 (Tuesday)	11,809	USD 7,416,052	USD 7,416,052	-112	USD -240,210	USD 628	USD 642.25
2025-11-03 (Monday)	11,921	USD 7,656,262	USD 7,656,262	0	USD -113,846	USD 642.25	USD 651.8
2025-10-31 (Friday)	11,921	USD 7,770,108	USD 7,770,108	53	USD 7,961	USD 651.8	USD 654.04
2025-10-30 (Thursday)	11,868	USD 7,762,147	USD 7,762,147	0	USD 13,411	USD 654.04	USD 652.91
2025-10-29 (Wednesday)	11,868	USD 7,748,736	USD 7,748,736	0	USD -18,633	USD 652.91	USD 654.48
2025-10-28 (Tuesday)	11,868	USD 7,767,369	USD 7,767,369	-108	USD 757,696	USD 654.48	USD 585.31
2025-10-27 (Monday)	11,976	USD 7,009,673	USD 7,009,673	0	USD 88,144	USD 585.31	USD 577.95

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of REGN by Blackrock for IE00BGPP8L80

Show aggregate share trades of REGN

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-04 SELL -112 646.221 625.140 627.248 USD -70,252 651.62 Profit of 2,730 on sale
2025-10-31 BUY 53 659.760 645.000 646.476 USD 34,263 651.67
2025-10-28 SELL -108 654.480 655.700 655.578 USD -70,802 651.63 Loss of -426 on sale
2025-10-21 SELL -106 579.340 582.410 582.103 USD -61,703 653.36 Profit of 7,553 on sale
2025-10-14 SELL -53 572.600 576.180 575.822 USD -30,519 655.32 Profit of 4,213 on sale
2025-10-02 SELL -217 600.000 605.410 604.869 USD -131,257 656.23 Profit of 11,145 on sale
2025-09-25 SELL -53 555.510 579.000 576.651 USD -30,563 658.50 Profit of 4,338 on sale
2025-09-16 BUY 48 575.060 579.400 578.966 USD 27,790 659.64
2025-09-12 SELL -212 560.000 570.000 569.000 USD -120,628 660.63 Profit of 19,426 on sale
2025-09-09 SELL -116 556.530 563.570 562.866 USD -65,292 662.26 Profit of 11,530 on sale
2025-07-28 SELL -88 558.630 567.950 567.018 USD -49,898 668.66 Profit of 8,945 on sale
2025-07-15 SELL -328 547.960 574.750 572.071 USD -187,639 672.18 Profit of 32,837 on sale
2025-07-11 SELL -164 567.740 568.460 568.388 USD -93,216 673.42 Profit of 17,226 on sale
2025-07-02 BUY 82 547.740 551.500 551.124 USD 45,192 678.92
2025-06-30 SELL -246 525.000 526.080 525.972 USD -129,389 679.89 Profit of 37,864 on sale
2025-06-27 SELL -264 521.000 531.210 530.189 USD -139,970 680.90 Profit of 39,789 on sale
2025-06-26 BUY 82 521.000 524.520 524.168 USD 42,982 681.93
2025-06-25 SELL -82 520.290 525.630 525.096 USD -43,058 682.97 Profit of 12,946 on sale
2025-06-23 SELL -249 511.920 516.180 515.754 USD -128,423 685.14 Profit of 42,177 on sale
2025-06-20 SELL -83 509.720 521.310 520.151 USD -43,173 686.29 Profit of 13,790 on sale
2025-06-16 SELL -832 522.680 538.200 536.648 USD -446,491 690.93 Profit of 128,365 on sale
2025-06-13 SELL -82 529.240 529.550 529.519 USD -43,421 692.03 Profit of 13,326 on sale
2025-06-12 SELL -164 521.840 525.220 524.882 USD -86,081 693.20 Profit of 27,604 on sale
2025-06-11 SELL -410 518.600 528.370 527.393 USD -216,231 694.40 Profit of 68,474 on sale
2025-06-09 SELL -82 517.600 518.270 518.203 USD -42,493 696.83 Profit of 14,648 on sale
2025-05-30 SELL -81 490.280 519.780 516.830 USD -41,863 705.96 Profit of 15,320 on sale
2025-05-28 SELL -81 591.850 606.000 604.585 USD -48,971 707.55 Profit of 8,340 on sale
2025-05-21 SELL -81 604.620 617.520 616.230 USD -49,915 711.83 Profit of 7,744 on sale
2025-05-14 SELL -1,105 571.360 580.560 579.640 USD -640,502 716.61 Profit of 151,353 on sale
2025-05-09 BUY 421 527.780 552.840 550.334 USD 231,691 720.48
2025-05-07 SELL -324 560.930 568.130 567.410 USD -183,841 723.25 Profit of 50,493 on sale
2025-05-01 BUY 81 590.000 593.930 593.537 USD 48,076 727.87
2025-04-29 SELL -902 568.910 579.980 578.873 USD -522,143 730.39 Profit of 136,671 on sale
2025-04-28 SELL -82 610.860 614.830 614.433 USD -50,384 731.45 Profit of 9,595 on sale
2025-04-25 BUY 82 602.640 602.790 602.775 USD 49,428 732.60
2025-04-23 BUY 847 587.850 603.770 602.178 USD 510,045 735.12
2025-04-22 BUY 720 585.490 587.100 586.939 USD 422,596 736.50
2025-04-15 SELL -240 557.910 575.200 573.471 USD -137,633 743.28 Profit of 40,755 on sale
2025-04-14 BUY 416 571.060 574.720 574.354 USD 238,931 744.94
2025-04-11 BUY 406 554.180 555.530 555.395 USD 225,490 746.79
2025-04-09 SELL -240 576.720 580.730 580.329 USD -139,279 750.46 Profit of 40,831 on sale
2025-04-08 SELL -320 556.810 586.030 583.108 USD -186,595 752.40 Profit of 54,172 on sale
2025-04-07 SELL -80 572.780 591.540 589.664 USD -47,173 754.21 Profit of 13,164 on sale
2025-04-04 BUY 80 573.450 612.990 609.036 USD 48,723 756.05
2025-04-01 BUY 320 617.000 641.240 638.816 USD 204,421 758.86
2025-03-27 SELL -160 635.830 643.430 642.670 USD -102,827 762.83 Profit of 19,226 on sale
2025-03-21 SELL -80 658.480 661.000 660.748 USD -52,860 767.97 Profit of 8,578 on sale
2025-03-14 BUY 240 666.870 686.980 684.969 USD 164,393 773.86
2025-03-13 BUY 80 680.610 698.950 697.116 USD 55,769 774.98
2025-03-12 BUY 160 689.500 712.460 710.164 USD 113,626 776.03
2025-03-11 BUY 160 718.160 747.700 744.746 USD 119,159 776.74
2025-03-10 SELL -80 744.830 748.290 747.944 USD -59,836 777.14 Profit of 2,336 on sale
2025-03-07 BUY 1,343 707.510 729.750 727.526 USD 977,067 778.02
2025-03-05 BUY 400 687.150 692.790 692.226 USD 276,890 779.19
2025-03-04 BUY 160 675.490 697.460 695.263 USD 111,242 780.53
2025-03-03 BUY 320 684.870 704.640 702.663 USD 224,852 781.79
2025-02-27 BUY 80 702.780 721.000 719.178 USD 57,534 783.98
2025-02-26 BUY 640 706.940 721.410 719.963 USD 460,776 785.04
2025-02-25 BUY 160 723.470 739.000 737.447 USD 117,992 785.89
2025-02-20 BUY 240 696.020 703.140 702.428 USD 168,583 789.49
2025-02-05 BUY 80 716.720 729.250 727.997 USD 58,240 808.95
2025-02-04 BUY 80 697.050 709.980 708.687 USD 56,695 810.91
2025-01-31 SELL -80 672.980 688.000 686.498 USD -54,920 816.04 Profit of 10,363 on sale
2025-01-30 BUY 80 683.080 689.620 688.966 USD 55,117 818.50
2025-01-29 SELL -80 687.270 697.570 696.540 USD -55,723 820.98 Profit of 9,955 on sale
2025-01-28 BUY 160 686.330 690.300 689.903 USD 110,384 823.57
2025-01-27 SELL -80 684.710 698.450 697.076 USD -55,766 826.29 Profit of 10,337 on sale
2024-12-10 SELL -80 778.500 791.490 790.191 USD -63,215 833.16 Profit of 3,438 on sale
2024-12-03 SELL -160 749.570 770.000 767.957 USD -122,873 840.79 Profit of 11,654 on sale
2024-11-29 SELL -80 750.220 754.510 754.081 USD -60,326 844.92 Profit of 7,267 on sale
2024-11-25 SELL -502 749.510 757.860 757.025 USD -380,027 860.76 Profit of 52,077 on sale
2024-11-25 SELL -502 749.510 757.860 757.025 USD -380,027 860.76 Profit of 52,077 on sale
2024-11-22 SELL -246 738.000 751.400 750.060 USD -184,515 864.37 Profit of 28,121 on sale
2024-11-05 SELL -656 829.430 836.630 835.910 USD -548,357 907.48 Profit of 46,951 on sale
2024-11-05 SELL -656 829.430 836.630 835.910 USD -548,357 907.48 Profit of 46,951 on sale
2024-10-29 BUY 82 927.330 932.380 931.875 USD 76,414 942.81
2024-10-29 BUY 82 927.330 932.380 931.875 USD 76,414 942.81
2024-10-24 BUY 82 928.900 952.020 949.708 USD 77,876 955.19
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-04	SELL	-112	646.221	625.140	627.248	USD -70,252	651.62 Profit of 2,730 on sale
2025-10-31	BUY	53	659.760	645.000	646.476	USD 34,263	651.67
2025-10-28	SELL	-108	654.480	655.700	655.578	USD -70,802	651.63 Loss of -426 on sale
2025-10-21	SELL	-106	579.340	582.410	582.103	USD -61,703	653.36 Profit of 7,553 on sale
2025-10-14	SELL	-53	572.600	576.180	575.822	USD -30,519	655.32 Profit of 4,213 on sale
2025-10-02	SELL	-217	600.000	605.410	604.869	USD -131,257	656.23 Profit of 11,145 on sale
2025-09-25	SELL	-53	555.510	579.000	576.651	USD -30,563	658.50 Profit of 4,338 on sale
2025-09-16	BUY	48	575.060	579.400	578.966	USD 27,790	659.64
2025-09-12	SELL	-212	560.000	570.000	569.000	USD -120,628	660.63 Profit of 19,426 on sale
2025-09-09	SELL	-116	556.530	563.570	562.866	USD -65,292	662.26 Profit of 11,530 on sale
2025-07-28	SELL	-88	558.630	567.950	567.018	USD -49,898	668.66 Profit of 8,945 on sale
2025-07-15	SELL	-328	547.960	574.750	572.071	USD -187,639	672.18 Profit of 32,837 on sale
2025-07-11	SELL	-164	567.740	568.460	568.388	USD -93,216	673.42 Profit of 17,226 on sale
2025-07-02	BUY	82	547.740	551.500	551.124	USD 45,192	678.92
2025-06-30	SELL	-246	525.000	526.080	525.972	USD -129,389	679.89 Profit of 37,864 on sale
2025-06-27	SELL	-264	521.000	531.210	530.189	USD -139,970	680.90 Profit of 39,789 on sale
2025-06-26	BUY	82	521.000	524.520	524.168	USD 42,982	681.93
2025-06-25	SELL	-82	520.290	525.630	525.096	USD -43,058	682.97 Profit of 12,946 on sale
2025-06-23	SELL	-249	511.920	516.180	515.754	USD -128,423	685.14 Profit of 42,177 on sale
2025-06-20	SELL	-83	509.720	521.310	520.151	USD -43,173	686.29 Profit of 13,790 on sale
2025-06-16	SELL	-832	522.680	538.200	536.648	USD -446,491	690.93 Profit of 128,365 on sale
2025-06-13	SELL	-82	529.240	529.550	529.519	USD -43,421	692.03 Profit of 13,326 on sale
2025-06-12	SELL	-164	521.840	525.220	524.882	USD -86,081	693.20 Profit of 27,604 on sale
2025-06-11	SELL	-410	518.600	528.370	527.393	USD -216,231	694.40 Profit of 68,474 on sale
2025-06-09	SELL	-82	517.600	518.270	518.203	USD -42,493	696.83 Profit of 14,648 on sale
2025-05-30	SELL	-81	490.280	519.780	516.830	USD -41,863	705.96 Profit of 15,320 on sale
2025-05-28	SELL	-81	591.850	606.000	604.585	USD -48,971	707.55 Profit of 8,340 on sale
2025-05-21	SELL	-81	604.620	617.520	616.230	USD -49,915	711.83 Profit of 7,744 on sale
2025-05-14	SELL	-1,105	571.360	580.560	579.640	USD -640,502	716.61 Profit of 151,353 on sale
2025-05-09	BUY	421	527.780	552.840	550.334	USD 231,691	720.48
2025-05-07	SELL	-324	560.930	568.130	567.410	USD -183,841	723.25 Profit of 50,493 on sale
2025-05-01	BUY	81	590.000	593.930	593.537	USD 48,076	727.87
2025-04-29	SELL	-902	568.910	579.980	578.873	USD -522,143	730.39 Profit of 136,671 on sale
2025-04-28	SELL	-82	610.860	614.830	614.433	USD -50,384	731.45 Profit of 9,595 on sale
2025-04-25	BUY	82	602.640	602.790	602.775	USD 49,428	732.60
2025-04-23	BUY	847	587.850	603.770	602.178	USD 510,045	735.12
2025-04-22	BUY	720	585.490	587.100	586.939	USD 422,596	736.50
2025-04-15	SELL	-240	557.910	575.200	573.471	USD -137,633	743.28 Profit of 40,755 on sale
2025-04-14	BUY	416	571.060	574.720	574.354	USD 238,931	744.94
2025-04-11	BUY	406	554.180	555.530	555.395	USD 225,490	746.79
2025-04-09	SELL	-240	576.720	580.730	580.329	USD -139,279	750.46 Profit of 40,831 on sale
2025-04-08	SELL	-320	556.810	586.030	583.108	USD -186,595	752.40 Profit of 54,172 on sale
2025-04-07	SELL	-80	572.780	591.540	589.664	USD -47,173	754.21 Profit of 13,164 on sale
2025-04-04	BUY	80	573.450	612.990	609.036	USD 48,723	756.05
2025-04-01	BUY	320	617.000	641.240	638.816	USD 204,421	758.86
2025-03-27	SELL	-160	635.830	643.430	642.670	USD -102,827	762.83 Profit of 19,226 on sale
2025-03-21	SELL	-80	658.480	661.000	660.748	USD -52,860	767.97 Profit of 8,578 on sale
2025-03-14	BUY	240	666.870	686.980	684.969	USD 164,393	773.86
2025-03-13	BUY	80	680.610	698.950	697.116	USD 55,769	774.98
2025-03-12	BUY	160	689.500	712.460	710.164	USD 113,626	776.03
2025-03-11	BUY	160	718.160	747.700	744.746	USD 119,159	776.74
2025-03-10	SELL	-80	744.830	748.290	747.944	USD -59,836	777.14 Profit of 2,336 on sale
2025-03-07	BUY	1,343	707.510	729.750	727.526	USD 977,067	778.02
2025-03-05	BUY	400	687.150	692.790	692.226	USD 276,890	779.19
2025-03-04	BUY	160	675.490	697.460	695.263	USD 111,242	780.53
2025-03-03	BUY	320	684.870	704.640	702.663	USD 224,852	781.79
2025-02-27	BUY	80	702.780	721.000	719.178	USD 57,534	783.98
2025-02-26	BUY	640	706.940	721.410	719.963	USD 460,776	785.04
2025-02-25	BUY	160	723.470	739.000	737.447	USD 117,992	785.89
2025-02-20	BUY	240	696.020	703.140	702.428	USD 168,583	789.49
2025-02-05	BUY	80	716.720	729.250	727.997	USD 58,240	808.95
2025-02-04	BUY	80	697.050	709.980	708.687	USD 56,695	810.91
2025-01-31	SELL	-80	672.980	688.000	686.498	USD -54,920	816.04 Profit of 10,363 on sale
2025-01-30	BUY	80	683.080	689.620	688.966	USD 55,117	818.50
2025-01-29	SELL	-80	687.270	697.570	696.540	USD -55,723	820.98 Profit of 9,955 on sale
2025-01-28	BUY	160	686.330	690.300	689.903	USD 110,384	823.57
2025-01-27	SELL	-80	684.710	698.450	697.076	USD -55,766	826.29 Profit of 10,337 on sale
2024-12-10	SELL	-80	778.500	791.490	790.191	USD -63,215	833.16 Profit of 3,438 on sale
2024-12-03	SELL	-160	749.570	770.000	767.957	USD -122,873	840.79 Profit of 11,654 on sale
2024-11-29	SELL	-80	750.220	754.510	754.081	USD -60,326	844.92 Profit of 7,267 on sale
2024-11-25	SELL	-502	749.510	757.860	757.025	USD -380,027	860.76 Profit of 52,077 on sale
2024-11-25	SELL	-502	749.510	757.860	757.025	USD -380,027	860.76 Profit of 52,077 on sale
2024-11-22	SELL	-246	738.000	751.400	750.060	USD -184,515	864.37 Profit of 28,121 on sale
2024-11-05	SELL	-656	829.430	836.630	835.910	USD -548,357	907.48 Profit of 46,951 on sale
2024-11-05	SELL	-656	829.430	836.630	835.910	USD -548,357	907.48 Profit of 46,951 on sale
2024-10-29	BUY	82	927.330	932.380	931.875	USD 76,414	942.81
2024-10-29	BUY	82	927.330	932.380	931.875	USD 76,414	942.81
2024-10-24	BUY	82	928.900	952.020	949.708	USD 77,876	955.19

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of REGN

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	208,659	1,635	312,812	66.7%
2025-09-18	236,485	3,679	387,519	61.0%
2025-09-17	229,191	716	370,895	61.8%
2025-09-16	173,632	584	271,020	64.1%
2025-09-15	204,491	251	334,496	61.1%
2025-09-12	117,504	33	222,760	52.7%
2025-09-11	125,478	3,137	286,516	43.8%
2025-09-10	195,068	481	339,885	57.4%
2025-09-09	129,168	994	274,520	47.1%
2025-09-08	250,895	396	527,062	47.6%
2025-09-05	170,149	290	289,566	58.8%
2025-09-04	188,227	2,103	360,619	52.2%
2025-09-03	185,679	344	438,111	42.4%
2025-09-02	191,954	138	476,288	40.3%
2025-08-29	133,226	685	236,726	56.3%
2025-08-28	116,560	2,177	256,675	45.4%
2025-08-27	113,719	465	243,836	46.6%
2025-08-26	210,376	450	400,199	52.6%
2025-08-25	149,130	68	363,377	41.0%
2025-08-22	211,822	3,244	701,770	30.2%
2025-08-21	257,492	3,416	446,439	57.7%
2025-08-20	327,738	572	559,133	58.6%
2025-08-19	118,472	2,191	324,311	36.5%
2025-08-18	146,282	388	277,909	52.6%
2025-08-15	209,923	3,375	441,752	47.5%
2025-08-14	157,569	3,623	429,327	36.7%
2025-08-13	111,342	233	362,786	30.7%
2025-08-12	117,647	171	310,775	37.9%
2025-08-11	129,513	2,676	284,757	45.5%
2025-08-08	128,559	1,038	431,841	29.8%
2025-08-07	166,648	1,560	352,877	47.2%
2025-08-06	176,311	624	397,089	44.4%
2025-08-05	154,257	115	353,744	43.6%
2025-08-04	200,758	1,913	409,897	49.0%
2025-08-01	349,775	3,745	728,720	48.0%
2025-07-31	222,350	476	549,344	40.5%
2025-07-30	106,839	1,689	231,761	46.1%
2025-07-29	149,359	276	292,667	51.0%
2025-07-28	103,687	1,380	245,287	42.3%
2025-07-25	103,783	556	259,069	40.1%
2025-07-24	156,974	2,397	291,677	53.8%
2025-07-23	168,734	1,708	355,372	47.5%
2025-07-22	116,324	617	304,880	38.2%
2025-07-21	98,482	900	250,107	39.4%
2025-07-18	183,174	1,051	391,909	46.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.